国内生物制药企业的研发一直进展缓慢,与国外发达国家相比存在很大差距。其中一个主要原因是机制问题。在国有企业改制中,我国不少企业创造了许多典型的改制模式,笔者认为值得借鉴,一、国企改革的模式目前我国较有影响力的国企改革模式可以归纳为以下 Domestic biopharmaceutical companies have been slow in R & D, compared with developed countries, there is a big gap. One of the main reasons is the mechanism. In the restructuring of state-owned enterprises, many Chinese enterprises have created many typical restructuring models, I think it is worth learning. First, the reform model of state-owned enterprises At present, China’s influential reform model of state-owned enterprises can be summarized as follows